Dr. Anastasios Raptis
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 249
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
PA license MD425540
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 249
- Services billed
- 1,280
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 368 | 59 |
| Established patient office or other outpatient visit, 40-54 minutes | 331 | 94 |
| Established patient office or other outpatient visit, 30-39 minutes | 142 | 96 |
| Established patient office or other outpatient visit, 20-29 minutes | 77 | 58 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Hospital discharge day management, more than 30 minutes | 25 | 21 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Pittsburgh, PA | 276 |
| Potassium Chloride Other prescribers in Pittsburgh, PA | 93 |
| Allopurinol Other prescribers in Pittsburgh, PA | 87 |
| Fluconazole Other prescribers in Pittsburgh, PA | 80 |
| Pantoprazole Sodium Other prescribers in Pittsburgh, PA | 72 |
| Dexamethasone Other prescribers in Pittsburgh, PA | 65 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Pittsburgh, PA | 61 |
| Pomalyst (pomalidomide) | 52 |
| Lenalidomide | 52 |
| Brukinsa (zanubrutinib) | 49 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $14.98 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $14.98 |
|---|
| Food and Beverage | $14.98 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.